Olema Pharmaceuticals (NASDAQ:OLMA) Given New $38.00 Price Target at Guggenheim

AI Briefing

• – Olema Pharmaceuticals price target reduced to $38.00 by Guggenheim, brokerage maintains buy rating
• – Guggenheim analyst trimmed price target, citing reasons not specified
• – Other analysts also have weighed in on the stock with various assessments